GlassScriptPhysician profile
Neha Gupta
NPI 1609144633
$3,808.09
in general payments reported to CMS, 2019-2025
13 companies · $1,227 in 2025
The $1,227 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.21 · 2021: $27.81 · 2023: $2,414 · 2024: $122 · 2025: $1,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,510 · Food and Beverage: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,510.00 |
| Food and Beverage | $1,254.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,177.76 | 2023-2025 | Venaseal, Closurefast |
| Angiodynamics, INC. | $239.17 | 2025 | Venacure 1470 Pro |
| Tactile Systems Technology INC | $109.59 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $73.78 | 2021-2023 | Fasenra |
| Koya Medical, INC. | $39.26 | 2025 | Dayspring, Koya Medical |
| Janssen Pharmaceuticals, INC | $28.38 | 2023 | Xarelto |
| Bard Peripheral Vascular, INC. | $27.95 | 2024 | Venclose Maven Catheter |
| Boston Scientific Corporation | $22.56 | 2024 | Varithena Administration Pack |
| Zoll Respicardia, INC. | $22.43 | 2025 | Remede System |
| Novo Nordisk INC | $17.81 | 2024 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $17.02 | 2024 | |
| Merck Sharp & Dohme LLC | $16.21 | 2019 | |
| Advanced Oxygen Therapy INC. | $16.17 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neha Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.